Waters Co. (WAT) Shares Sold by Linscomb & Williams Inc.

Share on StockTwits

Linscomb & Williams Inc. reduced its position in Waters Co. (NYSE:WAT) by 26.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,413 shares of the medical instruments supplier’s stock after selling 850 shares during the period. Linscomb & Williams Inc.’s holdings in Waters were worth $607,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in WAT. Stone Ridge Asset Management LLC boosted its position in Waters by 7.0% during the 4th quarter. Stone Ridge Asset Management LLC now owns 2,535 shares of the medical instruments supplier’s stock valued at $478,000 after purchasing an additional 166 shares during the period. Kinneret Advisory LLC acquired a new position in Waters during the 4th quarter valued at approximately $1,055,000. Ontario Teachers Pension Plan Board boosted its position in Waters by 6.7% during the 4th quarter. Ontario Teachers Pension Plan Board now owns 173,146 shares of the medical instruments supplier’s stock valued at $32,664,000 after purchasing an additional 10,815 shares during the period. IFM Investors Pty Ltd boosted its position in Waters by 10.5% during the 1st quarter. IFM Investors Pty Ltd now owns 4,985 shares of the medical instruments supplier’s stock valued at $1,255,000 after purchasing an additional 472 shares during the period. Finally, Stanley Laman Group Ltd. acquired a new position in Waters during the 4th quarter valued at approximately $4,084,000. 92.63% of the stock is currently owned by institutional investors and hedge funds.

Shares of WAT traded up $1.20 during midday trading on Monday, reaching $206.25. The stock had a trading volume of 435,951 shares, compared to its average volume of 548,764. The company has a market capitalization of $14.33 billion, a PE ratio of 24.88, a P/E/G ratio of 2.18 and a beta of 1.08. The company has a debt-to-equity ratio of 1.15, a quick ratio of 2.89 and a current ratio of 3.44. Waters Co. has a 52 week low of $167.93 and a 52 week high of $255.21.

Waters (NYSE:WAT) last announced its earnings results on Tuesday, April 23rd. The medical instruments supplier reported $1.60 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.73 by ($0.13). The company had revenue of $513.90 million for the quarter, compared to analyst estimates of $545.82 million. Waters had a return on equity of 39.64% and a net margin of 24.59%. The firm’s revenue for the quarter was down 3.2% on a year-over-year basis. During the same period last year, the firm earned $1.59 earnings per share. On average, equities research analysts forecast that Waters Co. will post 9.11 EPS for the current fiscal year.

In other Waters news, SVP Terrence P. Kelly sold 2,006 shares of the business’s stock in a transaction dated Monday, March 11th. The stock was sold at an average price of $239.69, for a total value of $480,818.14. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, SVP Robert G. Carson sold 2,724 shares of the business’s stock in a transaction dated Wednesday, March 6th. The shares were sold at an average price of $241.23, for a total value of $657,110.52. Following the completion of the transaction, the senior vice president now owns 3,898 shares in the company, valued at approximately $940,314.54. The disclosure for this sale can be found here. 1.14% of the stock is owned by insiders.

A number of research analysts have issued reports on WAT shares. Zacks Investment Research upgraded Waters from a “hold” rating to a “buy” rating and set a $256.00 price target for the company in a research report on Wednesday, January 30th. ValuEngine lowered Waters from a “buy” rating to a “hold” rating in a research report on Wednesday, April 24th. Barclays reduced their price target on Waters from $218.00 to $210.00 and set an “equal weight” rating for the company in a research report on Wednesday, April 24th. Robert W. Baird reduced their price target on Waters from $211.00 to $209.00 and set a “neutral” rating for the company in a research report on Wednesday, April 24th. Finally, UBS Group reduced their price target on Waters from $248.00 to $230.00 and set a “neutral” rating for the company in a research report on Wednesday, April 24th. Two research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has given a buy rating to the company’s stock. Waters currently has a consensus rating of “Hold” and a consensus target price of $212.26.

WARNING: This news story was posted by Ticker Report and is the property of of Ticker Report. If you are viewing this news story on another domain, it was illegally stolen and republished in violation of US & international trademark and copyright legislation. The original version of this news story can be read at https://www.tickerreport.com/banking-finance/4354199/waters-co-wat-shares-sold-by-linscomb-williams-inc.html.

About Waters

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

See Also: How to Trade Using Analysts Ratings

Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. (NYSE:WAT).

Institutional Ownership by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Autoliv  PT Lowered to $62.00 at Buckingham Research
Autoliv PT Lowered to $62.00 at Buckingham Research
Shotspotter  Cut to “Market Perform” at Northland Securities
Shotspotter Cut to “Market Perform” at Northland Securities
Buckingham Research Increases Sonic Automotive  Price Target to $20.00
Buckingham Research Increases Sonic Automotive Price Target to $20.00
Vail Resorts  Earns Market Perform Rating from Analysts at Wells Fargo & Co
Vail Resorts Earns Market Perform Rating from Analysts at Wells Fargo & Co
Johnson Outdoors  Downgraded by Sidoti
Johnson Outdoors Downgraded by Sidoti
Autoliv  Stock Rating Upgraded by Robert W. Baird
Autoliv Stock Rating Upgraded by Robert W. Baird


© 2006-2019 Ticker Report